Literature DB >> 6812089

The Gaucher mouse.

J N Kanfer, M C Stephens, H Singh, G Legler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6812089

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  8 in total

1.  Skin ultrastructural findings in type 2 Gaucher disease: diagnostic implications.

Authors:  Aegean Chan; Walter M Holleran; Tajh Ferguson; Debra Crumrine; Ozlem Goker-Alpan; Raphael Schiffmann; Nahid Tayebi; Edward I Ginns; Peter M Elias; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2011-09-16       Impact factor: 4.797

Review 2.  Approaches to labeling and identification of active site residues in glycosidases.

Authors:  S G Withers; R Aebersold
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

Review 3.  Gaucher disease: Progress and ongoing challenges.

Authors:  Pramod K Mistry; Grisel Lopez; Raphael Schiffmann; Norman W Barton; Neal J Weinreb; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2016-11-17       Impact factor: 4.797

4.  Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model.

Authors:  Nicole K Polinski; Terina N Martinez; Alexander Gorodinsky; Ralph Gareus; Michael Sasner; Mark Herberth; Robert Switzer; Syed O Ahmad; Mali Cosden; Monika Kandebo; Robert E Drolet; Peter D Buckett; Weisong Shan; Yi Chen; Lee J Pellegrino; Gregory D Ellsworth; Leo B Dungan; Warren D Hirst; Sean W Clark; Kuldip D Dave
Journal:  PLoS One       Date:  2021-06-09       Impact factor: 3.240

Review 5.  Necroptosis in neurodegenerative diseases: a potential therapeutic target.

Authors:  Shuo Zhang; Mi-Bo Tang; Hai-Yang Luo; Chang-He Shi; Yu-Ming Xu
Journal:  Cell Death Dis       Date:  2017-06-29       Impact factor: 8.469

Review 6.  Neuronopathic Gaucher disease: Beyond lysosomal dysfunction.

Authors:  Nohela B Arévalo; Cristian M Lamaizon; Viviana A Cavieres; Patricia V Burgos; Alejandra R Álvarez; María J Yañez; Silvana Zanlungo
Journal:  Front Mol Neurosci       Date:  2022-08-03       Impact factor: 6.261

7.  Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy.

Authors:  Chandra Sekhar Boddupalli; Shiny Nair; Glenn Belinsky; Joseph Gans; Erin Teeple; Tri-Hung Nguyen; Sameet Mehta; Lilu Guo; Martin L Kramer; Jiapeng Ruan; Honggge Wang; Matthew Davison; Dinesh Kumar; D J Vidyadhara; Bailin Zhang; Katherine Klinger; Pramod K Mistry
Journal:  Elife       Date:  2022-08-16       Impact factor: 8.713

8.  CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.

Authors:  John Marshall; Ying Sun; Dinesh S Bangari; Eva Budman; Hyejung Park; Jennifer B Nietupski; Amy Allaire; Mary A Cromwell; Bing Wang; Gregory A Grabowski; John P Leonard; Seng H Cheng
Journal:  Mol Ther       Date:  2016-03-07       Impact factor: 11.454
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.